TGFB1 and pulmonary fibrosis: DTP@DMF NPs can reduce macrophage accumulation and suppress the production of TGF-β and ROS to reduce fibroblast-to-myofibroblast transition and ECM deposition, thereby attenuating the progression of pulmonary fibrosis.